Wave Life Sciences Ltd. (WVE)
USD 5.6
(-3.45%)
USD 5.6
(-3.45%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 104.09 Million USD | 1710.19% |
| 2022 | -6.46 Million USD | 92.01% |
| 2021 | -80.91 Million USD | 22.27% |
| 2020 | -104.08 Million USD | 34.72% |
| 2019 | -159.44 Million USD | -32.86% |
| 2018 | -120.01 Million USD | -58.74% |
| 2017 | -75.6 Million USD | -7023.53% |
| 2016 | 1.09 Million USD | 112.26% |
| 2015 | -8.9 Million USD | -271.82% |
| 2014 | -2.39 Million USD | 48.03% |
| 2013 | -4.6 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q2 | 17.52 Million USD | -299.8% |
| 2024 Q1 | 10.36 Million USD | -61.45% |
| 2023 Q1 | 10.49 Million USD | 935.27% |
| 2023 FY | 104.09 Million USD | 1710.19% |
| 2023 Q2 | 19.78 Million USD | 88.58% |
| 2023 Q3 | 46.95 Million USD | 137.31% |
| 2023 Q4 | 26.87 Million USD | -42.76% |
| 2022 Q2 | -29.35 Million USD | -14.14% |
| 2022 Q4 | -1.25 Million USD | 45.77% |
| 2022 Q1 | -25.72 Million USD | -7.18% |
| 2022 FY | -6.46 Million USD | 92.01% |
| 2022 Q3 | -2.31 Million USD | 92.11% |
| 2021 Q1 | -2.46 Million USD | 82.19% |
| 2021 FY | -80.91 Million USD | 22.27% |
| 2021 Q4 | -23.99 Million USD | -549.62% |
| 2021 Q3 | 5.33 Million USD | 118.49% |
| 2021 Q2 | -28.85 Million USD | -1073.13% |
| 2020 Q2 | -28.45 Million USD | 23.1% |
| 2020 FY | -104.08 Million USD | 34.72% |
| 2020 Q3 | -24.82 Million USD | 12.74% |
| 2020 Q1 | -36.99 Million USD | 20.82% |
| 2020 Q4 | -13.81 Million USD | 44.35% |
| 2019 Q1 | -37.08 Million USD | -2.48% |
| 2019 Q3 | -41.65 Million USD | -22.6% |
| 2019 Q4 | -46.72 Million USD | -12.18% |
| 2019 FY | -159.44 Million USD | -32.86% |
| 2019 Q2 | -33.97 Million USD | 8.39% |
| 2018 Q3 | -28.38 Million USD | -2.58% |
| 2018 Q2 | -27.66 Million USD | 0.38% |
| 2018 Q1 | -27.77 Million USD | -17.22% |
| 2018 FY | -120.01 Million USD | -58.74% |
| 2018 Q4 | -36.18 Million USD | -27.5% |
| 2017 FY | -75.6 Million USD | -7023.53% |
| 2017 Q2 | -18.42 Million USD | -31.02% |
| 2017 Q3 | -19.42 Million USD | -5.39% |
| 2017 Q4 | -23.69 Million USD | -22.0% |
| 2017 Q1 | -14.06 Million USD | -5.59% |
| 2016 Q1 | -4.73 Million USD | -42.82% |
| 2016 FY | 1.09 Million USD | 112.26% |
| 2016 Q4 | -13.31 Million USD | -0.19% |
| 2016 Q3 | -13.29 Million USD | -66.51% |
| 2016 Q2 | -7.98 Million USD | -68.58% |
| 2015 FY | -8.9 Million USD | -271.82% |
| 2015 Q4 | -3.31 Million USD | -55.53% |
| 2015 Q3 | -2.13 Million USD | -23.67% |
| 2015 Q2 | -1.72 Million USD | -9.04% |
| 2015 Q1 | -1.58 Million USD | -118.67% |
| 2014 Q1 | -543.5 Thousand USD | 0.0% |
| 2014 Q3 | -585 Thousand USD | -7.64% |
| 2014 Q2 | -543.5 Thousand USD | 0.0% |
| 2014 Q4 | -723 Thousand USD | -23.59% |
| 2014 FY | -2.39 Million USD | 48.03% |
| 2013 FY | -4.6 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Akebia Therapeutics, Inc. | 120.47 Million USD | 13.592% |
| Jaguar Health, Inc. | 7.72 Million USD | -1247.734% |
| Keros Therapeutics, Inc. | -664 Thousand USD | 15777.56% |
| Longboard Pharmaceuticals, Inc. | -5000.00 USD | 2082080.0% |
| Alnylam Pharmaceuticals, Inc. | 1.51 Billion USD | 93.142% |
| Ligand Pharmaceuticals Incorporated | 119.75 Million USD | 13.072% |
| ContextLogic Inc. | 59 Million USD | -76.439% |
| MiMedx Group, Inc. | 266.84 Million USD | 60.989% |
| MEI Pharma, Inc. | 49.32 Million USD | -111.039% |
| AlloVir, Inc. | -398 Thousand USD | 26255.528% |
| Novavax, Inc. | 639.93 Million USD | 83.733% |
| Aptorum Group Limited | -1.11 Million USD | 9438.846% |
| Ardelyx, Inc. | 106.66 Million USD | 2.402% |
| Arrowhead Pharmaceuticals, Inc. | 240.73 Million USD | 56.758% |
| Psyence Biomedical Ltd. | -240.00 USD | 43374683.333% |
| Vaxcyte, Inc. | -75 Million USD | 238.799% |
| Precigen, Inc. | 106 Thousand USD | -98106.604% |
| Pharming Group N.V. | 220.1 Million USD | 52.705% |
| Phathom Pharmaceuticals, Inc. | 515 Thousand USD | -20113.398% |
| Pieris Pharmaceuticals, Inc. | 1 Million USD | -10217.047% |
| Rigel Pharmaceuticals, Inc. | 109.77 Million USD | 5.168% |
| Avidity Biosciences, Inc. | -181.4 Million USD | 157.384% |
| TransCode Therapeutics, Inc. | -516.74 Thousand USD | 20245.1% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Reviva Pharmaceuticals Holdings, Inc. | - USD | -Infinity% |
| Bicycle Therapeutics plc | -129.52 Million USD | 180.373% |
| Sangamo Therapeutics, Inc. | -45.32 Million USD | 329.672% |
| Sol-Gel Technologies Ltd. | -21.98 Million USD | 573.457% |
| Acelyrin, Inc. | -115 Thousand USD | 90620.87% |
| SELLAS Life Sciences Group, Inc. | - USD | -Infinity% |
| Sensei Biotherapeutics, Inc. | -571 Thousand USD | 18330.998% |
| Senti Biosciences, Inc. | -2.68 Million USD | 3979.948% |
| Stoke Therapeutics, Inc. | 4.05 Million USD | -2469.711% |
| AbCellera Biologics Inc. | 38.02 Million USD | -173.765% |
| Alaunos Therapeutics, Inc. | -4.79 Million USD | 2269.633% |
| BioXcel Therapeutics, Inc. | 120 Thousand USD | -86649.167% |
| Entrada Therapeutics, Inc. | 29.12 Million USD | -257.372% |
| Chimerix, Inc. | 324 Thousand USD | -32029.321% |
| VistaGen Therapeutics, Inc. | 496 Thousand USD | -20887.702% |
| Windtree Therapeutics, Inc. | -82 Thousand USD | 127050.0% |
| Corbus Pharmaceuticals Holdings, Inc. | -31.16 Million USD | 433.997% |
| Viracta Therapeutics, Inc. | -492 Thousand USD | 21258.333% |
| Elevation Oncology, Inc. | -39 Thousand USD | 267020.513% |
| Alkermes plc | 1.37 Billion USD | 92.427% |
| Fortress Biotech, Inc. | 57.85 Million USD | -79.937% |
| Fortress Biotech, Inc. | 57.85 Million USD | -79.937% |
| Agenus Inc. | 139.61 Million USD | 25.439% |
| HOOKIPA Pharma Inc. | 16.57 Million USD | -527.972% |
| Dyadic International, Inc. | 922.95 Thousand USD | -11178.857% |
| ImmuCell Corporation | 4.39 Million USD | -2267.886% |
| Eton Pharmaceuticals, Inc. | 21.06 Million USD | -394.274% |
| IDEAYA Biosciences, Inc. | -106.12 Million USD | 198.093% |
| Lantern Pharma Inc. | -174.84 Thousand USD | 59638.557% |
| Immix Biopharma, Inc. | -5468.00 USD | 1903885.662% |
| Incyte Corporation | 3.44 Billion USD | 96.974% |
| IO Biotech, Inc. | -756 Thousand USD | 13869.709% |
| Janux Therapeutics, Inc. | -46.83 Million USD | 322.249% |
| Inhibikase Therapeutics, Inc. | -13.35 Million USD | 879.31% |
| Outlook Therapeutics, Inc. | -44.18 Thousand USD | 235682.058% |
| Syros Pharmaceuticals, Inc. | -98.21 Million USD | 205.989% |
| Kintara Therapeutics, Inc. | -55 Thousand USD | 189370.909% |
| Barinthus Biotherapeutics plc | 802 Thousand USD | -12879.925% |
| Madrigal Pharmaceuticals, Inc. | -527 Thousand USD | 19853.131% |
| Sorrento Therapeutics, Inc. | 29.38 Million USD | -254.235% |
| NextCure, Inc. | -3.68 Million USD | 2925.706% |
| Ocuphire Pharma, Inc. | 19.04 Million USD | -446.652% |
| Onconetix, Inc. | -1.12 Million USD | 9335.471% |
| Oncternal Therapeutics, Inc. | -28.96 Million USD | 459.359% |
| Opthea Limited | 21.72 Thousand USD | -479177.164% |
| PDS Biotechnology Corporation | -57.32 Thousand USD | 181691.25% |
| PureTech Health plc | -1.6 Million USD | 6594.011% |
| Pyxis Oncology, Inc. | -2 Million USD | 5304.95% |
| Seer, Inc. | 7.02 Million USD | -1381.415% |
| Salarius Pharmaceuticals, Inc. | -10.05 Thousand USD | 1035807.89% |
| Clearside Biomedical, Inc. | 7.87 Million USD | -1222.564% |
| Telomir Pharmaceuticals, Inc. Common Stock | -3.94 Million USD | 2740.734% |
| VYNE Therapeutics Inc. | 424 Thousand USD | -24451.651% |
| Xeris Biopharma Holdings, Inc. | 135.26 Million USD | 23.043% |
| C4 Therapeutics, Inc. | -96.95 Million USD | 207.374% |
| ChromaDex Corporation | 50.78 Million USD | -105.0% |
| TRACON Pharmaceuticals, Inc. | -232 Thousand USD | 44970.259% |
| Caribou Biosciences, Inc. | -77.59 Million USD | 234.152% |
| CRISPR Therapeutics AG | 240.95 Million USD | 56.798% |
| Precision BioSciences, Inc. | 40.47 Million USD | -157.212% |
| Fate Therapeutics, Inc. | -98.16 Million USD | 206.047% |
| Innoviva, Inc. | 261.06 Million USD | 60.125% |
| Summit Therapeutics Inc. | -2.05 Million USD | 5178.0% |
| Verrica Pharmaceuticals Inc. | 4.37 Million USD | -2277.775% |
| Aadi Bioscience, Inc. | 21.54 Million USD | -383.17% |
| ESSA Pharma Inc. | -118.49 Thousand USD | 87953.93% |
| GlycoMimetics, Inc. | -143.3 Thousand USD | 72743.596% |
| GT Biopharma, Inc. | - USD | -Infinity% |
| Inhibrx Biosciences, Inc. | 609 Thousand USD | -16993.432% |
| Catalyst Pharmaceuticals, Inc. | 313.67 Million USD | 66.813% |
| Orchestra BioMed Holdings, Inc. | 2.57 Million USD | -3944.25% |
| Alzamend Neuro, Inc. | -50.74 Thousand USD | 205261.608% |
| Rocket Pharmaceuticals, Inc. | -7.09 Million USD | 1566.596% |
| Aptose Biosciences Inc. | -474.54 Thousand USD | 22036.592% |
| ZyVersa Therapeutics, Inc. | -10.4 Thousand USD | 1001051.923% |
| Soligenix, Inc. | 97.31 Thousand USD | -106875.573% |
| Century Therapeutics, Inc. | -10.8 Million USD | 1063.077% |
| Kura Oncology, Inc. | -849 Thousand USD | 12361.366% |
| TScan Therapeutics, Inc. | -67.1 Million USD | 255.131% |
| Intensity Therapeutics, Inc. | -147 Thousand USD | 70915.646% |
| Ocean Biomedical, Inc. | - USD | -Infinity% |
| CytomX Therapeutics, Inc. | 99.03 Million USD | -5.109% |
| Autolus Therapeutics plc | -4.86 Million USD | 2238.874% |
| Mineralys Therapeutics, Inc. | - USD | -Infinity% |
| EyePoint Pharmaceuticals, Inc. | 41.38 Million USD | -151.532% |
| Eterna Therapeutics Inc. | -168 Thousand USD | 62063.69% |
| Adaptive Biotechnologies Corporation | 94.72 Million USD | -9.898% |
| GRI Bio, Inc. | 10.84 Million USD | -860.234% |
| Xenetic Biosciences, Inc. | 2.53 Million USD | -3998.408% |
| Tenaya Therapeutics, Inc. | -8.68 Million USD | 1298.331% |
| IGM Biosciences, Inc. | -211.66 Million USD | 149.182% |
| INmune Bio, Inc. | 155 Thousand USD | -67060.645% |
| Heron Therapeutics, Inc. | 61.93 Million USD | -68.067% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7010.949% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16153.413% |
| Entero Therapeutics, Inc. | -29.27 Thousand USD | 355702.241% |
| Milestone Pharmaceuticals Inc. | 402 Thousand USD | -25795.274% |
| X4 Pharmaceuticals, Inc. | -1.99 Million USD | 5315.381% |
| Atara Biotherapeutics, Inc. | -313 Thousand USD | 33358.466% |
| Coherus BioSciences, Inc. | 94.46 Million USD | -10.203% |
| Verastem, Inc. | -62 Thousand USD | 168001.613% |
| Abeona Therapeutics Inc. | 2.43 Million USD | -4175.113% |
| Pliant Therapeutics, Inc. | -261 Thousand USD | 39984.674% |
| Tonix Pharmaceuticals Holding Corp. | 3.02 Million USD | -3339.016% |
| Histogen Inc. | 3.76 Million USD | -2661.979% |
| Aprea Therapeutics, Inc. | 576.17 Thousand USD | -17967.128% |
| Surrozen, Inc. | -27.23 Million USD | 482.295% |
| Organovo Holdings, Inc. | -5.38 Million USD | 2031.694% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Ovid Therapeutics Inc. | -1.2 Million USD | 8739.782% |
| Panbela Therapeutics, Inc. | -25.64 Million USD | 505.892% |
| CASI Pharmaceuticals, Inc. | 20.05 Million USD | -419.145% |
| Cadrenal Therapeutics, Inc. Common Stock | -1980.00 USD | 5257625.253% |
| Centessa Pharmaceuticals plc | 6.06 Million USD | -1615.987% |
| Hepion Pharmaceuticals, Inc. | -67.13 Thousand USD | 155168.448% |
| Arcturus Therapeutics Holdings Inc. | 154.79 Million USD | 32.749% |
| BioRestorative Therapies, Inc. | 145.8 Thousand USD | -71298.491% |
| Apollomics, Inc. | 127 Thousand USD | -81867.717% |
| Amarin Corporation plc | 165.54 Million USD | 37.116% |
| Mesoblast Limited | -9.81 Million USD | 1160.611% |
| Turnstone Biologics Corp. | 16.5 Million USD | -530.674% |
| Kymera Therapeutics, Inc. | -110.48 Million USD | 194.217% |
| Synaptogenix, Inc. | -6347.00 USD | 1640229.195% |
| Tiziana Life Sciences Ltd | -51 Thousand USD | 204215.686% |
| Aurinia Pharmaceuticals Inc. | 161.36 Million USD | 35.488% |
| BriaCell Therapeutics Corp. | - USD | -Infinity% |
| Monopar Therapeutics Inc. | - USD | -Infinity% |
| Exelixis, Inc. | 1.75 Billion USD | 94.077% |
| Better Therapeutics, Inc. | -2.72 Million USD | 3914.547% |
| Nurix Therapeutics, Inc. | -112.16 Million USD | 192.812% |
| Apellis Pharmaceuticals, Inc. | 338.08 Million USD | 69.209% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 912608.766% |
| Dermata Therapeutics, Inc. | - USD | -Infinity% |
| Aridis Pharmaceuticals, Inc. | - USD | -Infinity% |
| Gritstone bio, Inc. | -6.26 Million USD | 1762.923% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9495.217% |
| TNF Pharmaceuticals, Inc. | - USD | -Infinity% |
| Avid Bioservices, Inc. | 7.31 Million USD | -1322.506% |
| Insmed Incorporated | 239.63 Million USD | 56.559% |
| Virpax Pharmaceuticals, Inc. | - USD | -Infinity% |
| MediWound Ltd. | 3.57 Million USD | -2809.419% |
| OmniAb, Inc. | 14.66 Million USD | -609.75% |
| Alector, Inc. | -95.05 Million USD | 209.517% |
| Seres Therapeutics, Inc. | 125.62 Million USD | 17.132% |
| Checkpoint Therapeutics, Inc. | -43.46 Million USD | 339.512% |
| Zai Lab Limited | 170.9 Million USD | 39.089% |
| Revance Therapeutics, Inc. | 81.87 Million USD | -27.141% |
| Aura Biosciences, Inc. | -1.29 Million USD | 8138.533% |
| Lyell Immunopharma, Inc. | 130 Thousand USD | -79976.154% |
| Immunic, Inc. | -111 Thousand USD | 93882.883% |
| Tarsus Pharmaceuticals, Inc. | 15.85 Million USD | -556.61% |
| Veracyte, Inc. | 248.14 Million USD | 58.05% |
| InMed Pharmaceuticals Inc. | -6.98 Billion USD | 101.489% |
| FibroGen, Inc. | 128.9 Million USD | 19.243% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| Adial Pharmaceuticals, Inc. | -564.00 USD | 18457369.504% |
| Sonnet BioTherapeutics Holdings, Inc. | -11.66 Million USD | 992.26% |
| Jazz Pharmaceuticals plc | 3.39 Billion USD | 96.937% |
| Cyclacel Pharmaceuticals, Inc. | 389 Thousand USD | -26660.668% |
| Amylyx Pharmaceuticals, Inc. | 355.34 Million USD | 70.705% |
| TG Therapeutics, Inc. | 219.1 Million USD | 52.49% |
| Galecto, Inc. | -830 Thousand USD | 12642.048% |
| Calithera Biosciences, Inc. | -1.38 Million USD | 7616.173% |
| Fortrea Holdings Inc. | 424 Million USD | 75.448% |
| KalVista Pharmaceuticals, Inc. | -86.16 Million USD | 220.811% |
| Aptevo Therapeutics Inc. | -567 Thousand USD | 18459.612% |
| XBiotech Inc. | -1.74 Million USD | 6068.979% |
| Jasper Therapeutics, Inc. | -1.1 Million USD | 9495.217% |
| Lyra Therapeutics, Inc. | -46.47 Million USD | 324.009% |
| Foghorn Therapeutics Inc. | -75.53 Million USD | 237.817% |
| Y-mAbs Therapeutics, Inc. | 73.4 Million USD | -41.818% |
| Theravance Biopharma, Inc. | 16.8 Million USD | -519.526% |
| Ultragenyx Pharmaceutical Inc. | 389.04 Million USD | 73.242% |
| Metagenomi, Inc. Common Stock | -49.64 Million USD | 309.678% |
| Vaxxinity, Inc. | -2.23 Million USD | 4759.758% |
| BioCryst Pharmaceuticals, Inc. | 326.75 Million USD | 68.141% |
| Gain Therapeutics, Inc. | -11.32 Million USD | 1019.29% |
| Cartesian Therapeutics, Inc. | 24.45 Million USD | -325.745% |
| NexImmune, Inc. | -1.02 Million USD | 10256.277% |
| Creative Medical Technology Holdings, Inc. | 5400.00 USD | -1927659.259% |
| Marker Therapeutics, Inc. | -7.1 Million USD | 1565.016% |
| Regeneron Pharmaceuticals, Inc. | 11.3 Billion USD | 99.079% |
| Chemomab Therapeutics Ltd. | -66.82 Thousand USD | 155873.864% |
| Scopus BioPharma Inc. | - USD | -Infinity% |
| RAPT Therapeutics, Inc. | -3.55 Million USD | 3031.54% |
| Ainos, Inc. | -253.73 Thousand USD | 41126.985% |
| Pluri Inc. | 322 Thousand USD | -32228.882% |
| Prothena Corporation plc | -129.2 Million USD | 180.571% |
| Adaptimmune Therapeutics plc | 50.42 Million USD | -106.448% |
| Celularity Inc. | 6.75 Million USD | -1441.066% |
| Rallybio Corporation | -150 Thousand USD | 69499.333% |
| Cue Biopharma, Inc. | -32.6 Million USD | 419.254% |
| MeiraGTx Holdings plc | 287 Thousand USD | -36171.429% |
| Omeros Corporation | -69.77 Million USD | 249.184% |
| Humacyte, Inc. | -76.55 Million USD | 235.988% |
| Immunocore Holdings plc | 248.39 Million USD | 58.091% |
| Cocrystal Pharma, Inc. | -15.16 Million USD | 786.261% |
| Cidara Therapeutics, Inc. | 62.38 Million USD | -66.873% |
| Blueprint Medicines Corporation | 236.58 Million USD | 55.999% |
| CalciMedica, Inc. | -58 Thousand USD | 179581.034% |
| Cabaletta Bio, Inc. | -1.42 Million USD | 7400.07% |
| Marinus Pharmaceuticals, Inc. | 29.05 Million USD | -258.283% |
| Scholar Rock Holding Corporation | -2.84 Million USD | 3760.302% |
| Sana Biotechnology, Inc. | -30.86 Million USD | 437.272% |
| Pulmatrix, Inc. | -8.22 Million USD | 1366.411% |
| Elicio Therapeutics, Inc. | -1.17 Million USD | 8997.35% |
| Vigil Neuroscience, Inc. | -399 Thousand USD | 26189.975% |
| Intellia Therapeutics, Inc. | -398.79 Million USD | 126.103% |
| Adlai Nortye Ltd. American Depositary Shares | 2.77 Million USD | -3650.525% |
| Cytokinetics, Incorporated | -322.59 Million USD | 132.269% |
| Eloxx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11974.979% |
| Protara Therapeutics, Inc. | -341 Thousand USD | 30627.566% |
| Vor Biopharma Inc. | -3.49 Million USD | 3081.071% |
| Roivant Sciences Ltd. | 109.23 Million USD | 4.702% |
| Evogene Ltd. | 1.39 Million USD | -7340.958% |
| ProKidney Corp. | -3.16 Million USD | 3384.916% |
| Applied Therapeutics, Inc. | -43.91 Million USD | 337.063% |
| Hoth Therapeutics, Inc. | - USD | -Infinity% |
| BridgeBio Pharma, Inc. | 6.85 Million USD | -1418.142% |
| CorMedix Inc. | -205.56 Thousand USD | 50741.169% |
| BioLineRx Ltd. | 1.1 Million USD | -9295.217% |
| Tango Therapeutics, Inc. | -78.67 Million USD | 232.322% |
| Galectin Therapeutics Inc. | -33 Thousand USD | 315551.515% |
| Atai Life Sciences N.V. | -5000.00 USD | 2082080.0% |
| Renovaro Biosciences Inc. | -121.85 Thousand USD | 85525.779% |
| Aerovate Therapeutics, Inc. | -96 Thousand USD | 108536.458% |
| Zentalis Pharmaceuticals, Inc. | -1.38 Million USD | 7594.528% |
| Sagimet Biosciences Inc. | 2 Million USD | -5104.95% |
| MediciNova, Inc. | 979.7 Thousand USD | -10525.545% |
| Praxis Precision Medicines, Inc. | -84.31 Million USD | 223.459% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 110193.596% |
| GeoVax Labs, Inc. | -20.72 Million USD | 602.39% |
| Axsome Therapeutics, Inc. | 244.53 Million USD | 57.43% |
| Biomea Fusion, Inc. | -4.2 Million USD | 2577.958% |
| PTC Therapeutics, Inc. | 872.33 Million USD | 88.067% |
| Mereo BioPharma Group plc | 7.42 Million USD | -1301.818% |
| Cullinan Oncology, Inc. | -310 Thousand USD | 33680.323% |
| Syndax Pharmaceuticals, Inc. | -12 Thousand USD | 867591.667% |
| Absci Corporation | -41.84 Million USD | 348.749% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2082080.0% |
| 4D Molecular Therapeutics, Inc. | -76.37 Million USD | 236.303% |
| Dyne Therapeutics, Inc. | -2.46 Million USD | 4329.947% |
| Kiniksa Pharmaceuticals, Ltd. | 213.73 Million USD | 51.295% |
| Ventyx Biosciences, Inc. | -941 Thousand USD | 11162.593% |
| Allakos Inc. | -6.14 Million USD | 1795.147% |
| Imunon, Inc. | -720 Thousand USD | 14558.094% |
| Fulcrum Therapeutics, Inc. | -68.99 Million USD | 250.877% |
| Corcept Therapeutics Incorporated | 475.89 Million USD | 78.126% |
| BioAtla, Inc. | -103.73 Million USD | 200.355% |
| NLS Pharmaceutics AG | -11.4 Thousand USD | 912608.766% |
| Bio-Path Holdings, Inc. | -178 Thousand USD | 58582.584% |
| Allogene Therapeutics, Inc. | -242.81 Million USD | 142.871% |
| Larimar Therapeutics, Inc. | -311 Thousand USD | 33572.347% |
| XOMA Corporation | 3.86 Million USD | -2596.167% |
| Kezar Life Sciences, Inc. | -70.08 Million USD | 248.532% |
| Cara Therapeutics, Inc. | 14.79 Million USD | -603.657% |
| aTyr Pharma, Inc. | -2.38 Million USD | 4459.255% |
| Aligos Therapeutics, Inc. | 12.46 Million USD | -735.465% |
| Akero Therapeutics, Inc. | -29 Thousand USD | 359062.069% |
| Viridian Therapeutics, Inc. | -1 Million USD | 10427.282% |
| Eliem Therapeutics, Inc. | - USD | -Infinity% |
| EyeGate Pharmaceuticals, Inc. | 13.00 USD | -800761438.462% |
| Akari Therapeutics, Plc | -4000.00 USD | 2602575.0% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Halozyme Therapeutics, Inc. | 636.89 Million USD | 83.655% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -53364.162% |
| UroGen Pharma Ltd. | 73.35 Million USD | -41.917% |
| Sutro Biopharma, Inc. | -26.69 Million USD | 489.972% |
| ZIVO Bioscience, Inc. | 11.61 Thousand USD | -896532.214% |
| Orgenesis Inc. | -5.72 Million USD | 1918.323% |
| Entera Bio Ltd. | -56 Thousand USD | 185991.071% |
| GH Research PLC | -315 Thousand USD | 33147.302% |
| Lisata Therapeutics, Inc. | -189 Thousand USD | 55178.836% |
| Reneo Pharmaceuticals, Inc. | -525 Thousand USD | 19928.381% |
| Xencor, Inc. | -85.26 Million USD | 222.096% |
| 60 Degrees Pharmaceuticals, Inc. | -220.97 Thousand USD | 47208.523% |
| Replimune Group, Inc. | -2.65 Million USD | 4020.866% |
| Coeptis Therapeutics Holdings, Inc. | -1 Million USD | 10497.049% |
| Vanda Pharmaceuticals Inc. | 177.84 Million USD | 41.466% |
| Lexaria Bioscience Corp. | 194.7 Thousand USD | -53364.162% |
| Portage Biotech Inc. | -54 Thousand USD | 192875.926% |
| Cardio Diagnostics Holdings, Inc. | -94.55 Thousand USD | 110193.596% |
| Olema Pharmaceuticals, Inc. | -377 Thousand USD | 27712.467% |
| OncoCyte Corporation | 413 Thousand USD | -25105.569% |
| Qualigen Therapeutics, Inc. | -4495.00 USD | 2315984.316% |
| Processa Pharmaceuticals, Inc. | -222.00 USD | 46891541.441% |
| Purple Biotech Ltd. | -196 Thousand USD | 53211.735% |
| CollPlant Biotechnologies Ltd. | 8.96 Million USD | -1060.783% |
| scPharmaceuticals Inc. | 9.78 Million USD | -964.189% |
| ProMIS Neurosciences, Inc. | -10.44 Million USD | 1096.644% |
| HilleVax, Inc. | -2.15 Million USD | 4928.34% |
| NeuroSense Therapeutics Ltd. | -97 Thousand USD | 107418.557% |
| Tharimmune, Inc. | - USD | -Infinity% |
| Genprex, Inc. | -15 Thousand USD | 693908.318% |
| Neumora Therapeutics, Inc. Common Stock | -668 Thousand USD | 15683.683% |
| Atossa Therapeutics, Inc. | -23 Thousand USD | 452704.348% |
| XTL Biopharmaceuticals Ltd. | - USD | -Infinity% |
| Virios Therapeutics, Inc. | - USD | -Infinity% |
| OKYO Pharma Limited | -7506.16 USD | 1386947.603% |
| Savara Inc. | -44.26 Million USD | 335.188% |
| Curis, Inc. | 9.81 Million USD | -961.044% |
| Daré Bioscience, Inc. | 2.76 Million USD | -3658.735% |
| Carmell Therapeutics Corporation | -124.78 Thousand USD | 83520.681% |
| Titan Pharmaceuticals, Inc. | -1.72 Million USD | 6120.763% |
| Achieve Life Sciences, Inc. | -228 Thousand USD | 45757.456% |
| BeiGene, Ltd. | 2.07 Billion USD | 94.992% |
| Kiromic BioPharma, Inc. | -2.79 Million USD | 3823.273% |
| Revolution Medicines, Inc. Warrant | -399.66 Million USD | 126.047% |
| Protagonist Therapeutics, Inc. | 56.68 Million USD | -83.635% |
| Erasca, Inc. | -3.73 Million USD | 2889.362% |
| bluebird bio, Inc. | -4.03 Million USD | 2683.102% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 369009.916% |
| BioMarin Pharmaceutical Inc. | 1.9 Billion USD | 94.534% |
| DBV Technologies S.A. | 15.72 Million USD | -561.871% |
| Protagenic Therapeutics, Inc. | -28.21 Thousand USD | 369009.916% |
| Moderna, Inc. | 2.15 Billion USD | 95.169% |
| Vincerx Pharma, Inc. | -915 Thousand USD | 11476.94% |
| Fresh Tracks Therapeutics, Inc. | 8 Million USD | -1200.262% |
| Molecular Templates, Inc. | 50.39 Million USD | -106.566% |
| Acrivon Therapeutics, Inc. Common Stock | -536 Thousand USD | 19521.455% |
| Travere Therapeutics, Inc. | 133.78 Million USD | 22.191% |
| Monte Rosa Therapeutics, Inc. | -6.22 Million USD | 1773.079% |
| Spruce Biosciences, Inc. | -39.34 Million USD | 364.593% |
| Celldex Therapeutics, Inc. | -111.12 Million USD | 193.675% |
| Cogent Biosciences, Inc. | -3.58 Million USD | 3001.31% |
| MacroGenics, Inc. | 50.52 Million USD | -106.026% |
| RenovoRx, Inc. | - USD | -Infinity% |
| Adicet Bio, Inc. | -6.09 Million USD | 1807.101% |
| Prime Medicine, Inc. | -147.9 Million USD | 170.382% |
| Aditxt, Inc. | -111.66 Thousand USD | 93328.551% |
| Adagene Inc. | 18.11 Million USD | -474.768% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Quantum-Si incorporated | 488 Thousand USD | -21231.762% |
| Maravai LifeSciences Holdings, Inc. | 140.2 Million USD | 25.751% |
| Acurx Pharmaceuticals, Inc. | - USD | -Infinity% |
| Voyager Therapeutics, Inc. | 157.83 Million USD | 34.046% |
| SciSparc Ltd. | 2.19 Million USD | -4640.392% |
| Vericel Corporation | 135.57 Million USD | 23.217% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 415681.46% |
| Minerva Neurosciences, Inc. | -30.98 Thousand USD | 336098.322% |
| Generation Bio Co. | -73.91 Million USD | 240.844% |
| Astria Therapeutics, Inc. | - USD | -Infinity% |
| Black Diamond Therapeutics, Inc. | -437 Thousand USD | 23921.281% |
| Arcutis Biotherapeutics, Inc. | 54.61 Million USD | -90.591% |
| Invivyd, Inc. | -2.02 Million USD | 5233.087% |
| Relay Therapeutics, Inc. | -300.84 Million USD | 134.603% |
| Quoin Pharmaceuticals, Ltd. | -103.43 Thousand USD | 100739.03% |
| Spero Therapeutics, Inc. | 96.36 Million USD | -8.022% |
| Artelo Biosciences, Inc. | - USD | -Infinity% |
| 2seventy bio, Inc. | 98.28 Million USD | -5.912% |
| ADMA Biologics, Inc. | 88.21 Million USD | -18.002% |
| Clene Inc. | 533 Thousand USD | -19430.769% |
| Capricor Therapeutics, Inc. | 24.1 Million USD | -331.782% |
| Boundless Bio, Inc. Common Stock | -957 Thousand USD | 10977.638% |
| GeoVax Labs, Inc. | -20.72 Million USD | 602.39% |
| Recursion Pharmaceuticals, Inc. | 1.98 Million USD | -5136.368% |
| Citius Pharmaceuticals, Inc. | -194.31 Thousand USD | 53672.017% |
| Contineum Therapeutics, Inc. Class A Common Stock | 49.8 Million USD | -109.013% |
| Relmada Therapeutics, Inc. | - USD | -Infinity% |
| Finch Therapeutics Group, Inc. | -7.09 Million USD | 1567.837% |
| ALX Oncology Holdings Inc. | -836 Thousand USD | 12552.033% |
| Vir Biotechnology, Inc. | 83.41 Million USD | -24.796% |
| Evaxion Biotech A/S | 73.11 Thousand USD | -142282.919% |
| Ocular Therapeutix, Inc. | 53.16 Million USD | -95.815% |
| Verve Therapeutics, Inc. | -173.18 Million USD | 160.108% |
| Trevena, Inc. | 1.45 Million USD | -7054.57% |
| Surrozen, Inc. | -27.23 Million USD | 482.295% |
| Tyra Biosciences, Inc. | -353 Thousand USD | 29589.802% |
| Cingulate Inc. | -582.91 Thousand USD | 17958.258% |
| Galmed Pharmaceuticals Ltd. | -31 Thousand USD | 335903.226% |
| Unity Biotechnology, Inc. | -19.69 Million USD | 628.448% |
| Tenax Therapeutics, Inc. | -7570.00 USD | 1375251.915% |
| Terns Pharmaceuticals, Inc. | -881 Thousand USD | 11916.005% |
| ACADIA Pharmaceuticals Inc. | 680.7 Million USD | 84.707% |
| Connect Biopharma Holdings Limited | -988 Thousand USD | 10636.336% |
| Clearmind Medicine Inc. | -56.34 Thousand USD | 184862.699% |
| Kronos Bio, Inc. | 1.37 Million USD | -7487.391% |
| Bolt Biotherapeutics, Inc. | -53.66 Million USD | 293.976% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Viking Therapeutics, Inc. | -292 Thousand USD | 35750.342% |
| Statera Biopharma, Inc. | -488.31 Thousand USD | 21418.045% |
| ImmunityBio, Inc. | -17.89 Million USD | 681.884% |
| Korro Bio, Inc. | -3.63 Million USD | 2967.741% |
| Kineta, Inc. | 5.43 Million USD | -1816.05% |
| BioVie Inc. | -229.37 Thousand USD | 45483.365% |
| Codexis, Inc. | 57.33 Million USD | -81.566% |
| Celularity Inc. | 6.75 Million USD | -1441.066% |
| Crinetics Pharmaceuticals, Inc. | 4.01 Million USD | -2494.044% |
| Celcuity Inc. | -142.77 Thousand USD | 73012.756% |
| Virax Biolabs Group Limited | 50.59 Thousand USD | -205669.915% |
| Cibus, Inc. | 1.42 Million USD | -7220.605% |
| Eledon Pharmaceuticals, Inc. | -374 Thousand USD | 27933.957% |
| eFFECTOR Therapeutics, Inc. | -22.91 Million USD | 554.204% |
| IN8bio, Inc. | -2.5 Million USD | 4262.295% |
| Kodiak Sciences Inc. | -25.94 Million USD | 501.199% |
| Annexon, Inc. | -3.26 Million USD | 3286.379% |
| Adverum Biotechnologies, Inc. | -2.04 Million USD | 5192.906% |
| Assembly Biosciences, Inc. | -41.73 Million USD | 349.417% |
| Avalo Therapeutics, Inc. | 640 Thousand USD | -16165.469% |
| Ionis Pharmaceuticals, Inc. | 778.51 Million USD | 86.628% |
| Eyenovia, Inc. | - USD | -Infinity% |
| Puma Biotechnology, Inc. | 172.95 Million USD | 39.812% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| Xilio Therapeutics, Inc. | -1.9 Million USD | 5578.895% |
| Arcellx, Inc. | 108.27 Million USD | 3.86% |
| Cardiff Oncology, Inc. | -32.36 Million USD | 421.601% |
| Enanta Pharmaceuticals, Inc. | 79.2 Million USD | -31.431% |
| Regulus Therapeutics Inc. | -21.15 Million USD | 592.147% |
| Moolec Science SA | -143.3 Thousand USD | 72741.569% |
| Acumen Pharmaceuticals, Inc. | -42.31 Million USD | 345.992% |
| Geron Corporation | -123.5 Million USD | 184.289% |
| LAVA Therapeutics N.V. | 3.28 Million USD | -3066.991% |
| Royalty Pharma plc | 1.79 Billion USD | 94.197% |
| Atea Pharmaceuticals, Inc. | -70.09 Million USD | 248.522% |
| Greenwich LifeSciences, Inc. | -3612.00 USD | 2882132.115% |
| TFF Pharmaceuticals, Inc. | 231.39 Thousand USD | -44888.353% |
| Mersana Therapeutics, Inc. | -111.41 Million USD | 193.434% |
| Humacyte, Inc. | -76.55 Million USD | 235.988% |
| Structure Therapeutics Inc. | -949.17 Thousand USD | 11067.325% |
| 89bio, Inc. | -273 Thousand USD | 38231.502% |
| PMV Pharmaceuticals, Inc. | -1.25 Million USD | 8381.543% |
| Avenue Therapeutics, Inc. | - USD | -Infinity% |
| Genelux Corporation | -848 Thousand USD | 12375.825% |
| Trevi Therapeutics, Inc. | -123 Thousand USD | 84733.333% |
| Lexicon Pharmaceuticals, Inc. | 1.11 Million USD | -9202.86% |
| Notable Labs, Ltd. | 113 Thousand USD | -92023.009% |
| Liquidia Corporation | 14.6 Million USD | -613.007% |
| Mustang Bio, Inc. | -2.22 Million USD | 4778.607% |
| Immunovant, Inc. | -231 Thousand USD | 45164.502% |
| Quantum-Si incorporated | 488 Thousand USD | -21231.762% |
| Arbutus Biopharma Corporation | -55.55 Million USD | 287.367% |
| DiaMedica Therapeutics Inc. | -30 Thousand USD | 347096.667% |
| Vera Therapeutics, Inc. | 1.86 Million USD | -5490.709% |
| Acasti Pharma Inc. | -11 Thousand USD | 946454.545% |
| MiNK Therapeutics, Inc. | -204.61 Thousand USD | 50975.049% |
| Pasithea Therapeutics Corp. | -648.45 Thousand USD | 16153.413% |
| Xenon Pharmaceuticals Inc. | -167.51 Million USD | 162.144% |
| Elevai Labs, Inc. Common Stock | 1.13 Million USD | -9075.113% |
| NeuroBo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Tempest Therapeutics, Inc. | -381 Thousand USD | 27422.572% |
| Soleno Therapeutics, Inc. | -1.95 Million USD | 5416.599% |
| PepGen Inc. | -1.18 Million USD | 8892.145% |
| Moleculin Biotech, Inc. | -127 Thousand USD | 82067.717% |
| United Therapeutics Corporation | 2.07 Billion USD | 94.971% |
| Nuvectis Pharma, Inc. | -22.89 Million USD | 554.64% |
| Solid Biosciences Inc. | -76.56 Million USD | 235.965% |
| BriaCell Therapeutics Corp. | -82.58 Thousand USD | 126153.788% |
| Immuneering Corporation | -764.13 Thousand USD | 13723.063% |
| Lixte Biotechnology Holdings, Inc. | - USD | -Infinity% |
| Silo Pharma, Inc. | 66.26 Thousand USD | -156997.368% |
| Belite Bio, Inc | -399 Thousand USD | 26189.975% |
| XOMA Corporation | 3.86 Million USD | -2596.167% |
| ARS Pharmaceuticals, Inc. | -20.03 Million USD | 619.56% |
| Bionomics Limited | -434.44 Thousand USD | 24061.155% |
| Apogee Therapeutics, Inc. | - USD | -Infinity% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9792.644% |
| uniQure N.V. | 2.21 Million USD | -4599.729% |
| Cassava Sciences, Inc. | -89.42 Million USD | 216.412% |
| Estrella Immunopharma, Inc. | - USD | -Infinity% |
| Poseida Therapeutics, Inc. | -92.06 Million USD | 213.066% |
| Forte Biosciences, Inc. | -9000.00 USD | 1156755.556% |
| Anebulo Pharmaceuticals, Inc. | - USD | -Infinity% |
| Enlivex Therapeutics Ltd. | -835 Thousand USD | 12566.946% |
| Conduit Pharmaceuticals Inc. | - USD | -Infinity% |
| SeaStar Medical Holding Corporation | - USD | -Infinity% |
| FibroBiologics, Inc. Common Stock | -437 Thousand USD | 23921.281% |
| Altimmune, Inc. | -65.37 Million USD | 259.239% |
| Amicus Therapeutics, Inc. | 362.03 Million USD | 71.246% |
| Alpha Tau Medical Ltd. | -1.07 Million USD | 9792.644% |
| Compugen Ltd. | 31.45 Million USD | -230.946% |
| Peak Bio, Inc. | 367.76 Thousand USD | -28205.54% |
| Zevra Therapeutics, Inc. | 24.51 Million USD | -324.617% |
| Benitec Biopharma Inc. | 108 Thousand USD | -96287.963% |
| Spyre Therapeutics, Inc. | -78 Thousand USD | 133560.256% |
| NKGen Biotech, Inc. Common Stock | -1.2 Million USD | 8753.283% |
| Zura Bio Limited | - USD | -Infinity% |
| PolyPid Ltd. | -1.82 Million USD | 5813.447% |
| Aileron Therapeutics, Inc. | -119 Thousand USD | 87578.151% |
| NKGen Biotech, Inc. Warrants | -1.2 Million USD | 8753.283% |
| Instil Bio, Inc. | -4.75 Million USD | 2288.793% |
| argenx SE | 1.1 Billion USD | 90.609% |
| Immunome, Inc. | -8.9 Million USD | 1268.732% |
| Compass Therapeutics, Inc. | -1.89 Million USD | 5607.884% |
| Verona Pharma plc | -679.62 Thousand USD | 15417.146% |
| enGene Holdings Inc. Warrants | -175 Thousand USD | 59585.143% |
| Shattuck Labs, Inc. | -2.38 Million USD | 4464.738% |
| CervoMed Inc. | -1.29 Million USD | 8147.065% |
| LENZ Therapeutics, Inc. | -2.4 Million USD | 4424.844% |
| Plus Therapeutics, Inc. | -4.77 Million USD | 2279.171% |
| Dianthus Therapeutics, Inc. | 2.47 Million USD | -4112.829% |
| Moolec Science SA | -143.3 Thousand USD | 72741.569% |
| Enveric Biosciences, Inc. | -408.03 Thousand USD | 25612.585% |
| Inovio Pharmaceuticals, Inc. | -2.67 Million USD | 3996.609% |
| AnaptysBio, Inc. | 14.78 Million USD | -604.276% |
| Design Therapeutics, Inc. | -537 Thousand USD | 19485.289% |
| Leap Therapeutics, Inc. | -427 Thousand USD | 24479.157% |
| NeurAxis, Inc. | 2.15 Million USD | -4726.763% |
| Seelos Therapeutics, Inc. | 2.14 Million USD | -4750.839% |
| Lumos Pharma, Inc. | 2 Million USD | -5086.796% |
| Achilles Therapeutics plc | -4.73 Million USD | 2300.235% |
| enGene Holdings Inc. Common Stock | -175 Thousand USD | 59585.143% |
| 180 Life Sciences Corp. | -105.67 Thousand USD | 98608.635% |
| Opiant Pharmaceuticals, Inc. | 31.65 Million USD | -228.816% |
| CERo Therapeutics Holdings, Inc. | - USD | -Infinity% |
| Nutriband Inc. | 862.1 Thousand USD | -11974.979% |
| ORIC Pharmaceuticals, Inc. | -1.03 Million USD | 10187.112% |
| CG Oncology, Inc. Common stock | -45.54 Million USD | 328.548% |
| Fractyl Health, Inc. Common Stock | 43 Thousand USD | -241990.698% |
| Rani Therapeutics Holdings, Inc. | -822 Thousand USD | 12764.112% |
| MoonLake Immunotherapeutics | -13.15 Thousand USD | 791246.071% |
| Palisade Bio, Inc. | 246 Thousand USD | -42216.667% |
| Tourmaline Bio, Inc. | -33 Thousand USD | 315551.515% |
| Beam Therapeutics Inc. | -59.67 Million USD | 274.452% |
| Neurogene Inc. | -3.26 Million USD | 3291.263% |
| Mirum Pharmaceuticals, Inc. | 139.33 Million USD | 25.289% |
| AEON Biopharma, Inc. | - USD | -Infinity% |
| CARGO Therapeutics, Inc. Common Stock | -3.69 Million USD | 2919.583% |
| Sesen Bio, Inc. | 40 Million USD | -160.248% |
| Enliven Therapeutics, Inc. | -297 Thousand USD | 35150.168% |
| Kiora Pharmaceuticals, Inc. | -4.02 Million USD | 2685.002% |
| Iovance Biotherapeutics, Inc. | -9.56 Million USD | 1188.219% |
| Taysha Gene Therapies, Inc. | 14.08 Million USD | -639.339% |
| Athira Pharma, Inc. | -969 Thousand USD | 10842.931% |
| Vaccinex, Inc. | -16 Million USD | 750.456% |
| HCW Biologics Inc. | -574.82 Thousand USD | 18209.717% |
| XOMA Corporation | 3.86 Million USD | -2596.167% |
| Nektar Therapeutics | 53.47 Million USD | -94.658% |
| Arvinas, Inc. | 71.8 Million USD | -44.985% |
| Tevogen Bio Holdings Inc. | - USD | -Infinity% |
| Merus N.V. | -83.46 Million USD | 224.728% |
| Omega Therapeutics, Inc. | -62.77 Million USD | 265.829% |
| Quince Therapeutics, Inc. | -322 Thousand USD | 32428.882% |
| Rezolute, Inc. | -36 Thousand USD | 289263.889% |
| Clene Inc. | 533 Thousand USD | -19430.769% |
| Indaptus Therapeutics, Inc. | -1284.00 USD | 8107498.754% |
| BeyondSpring Inc. | 1.75 Million USD | -5845.117% |
| Synlogic, Inc. | -1.92 Million USD | 5510.551% |
| Allarity Therapeutics, Inc. | -37 Thousand USD | 281448.649% |
| Phio Pharmaceuticals Corp. | -6.33 Million USD | 1744.015% |
| Peak Bio, Inc. | 367.76 Thousand USD | -28205.54% |
| Werewolf Therapeutics, Inc. | -18.96 Million USD | 648.958% |
| Krystal Biotech, Inc. | 47.6 Million USD | -118.672% |
| Karyopharm Therapeutics Inc. | 141.09 Million USD | 26.219% |
| SpringWorks Therapeutics, Inc. | 5.02 Million USD | -1971.622% |
| Lipella Pharmaceuticals Inc. | -2.58 Million USD | 4120.479% |
| MannKind Corporation | 136.19 Million USD | 23.564% |
| Ikena Oncology, Inc. | -50.49 Million USD | 306.169% |
| Cyclerion Therapeutics, Inc. | - USD | -Infinity% |
| Gyre Therapeutics, Inc. | 108.81 Million USD | 4.333% |
| Gossamer Bio, Inc. | -4.38 Million USD | 2473.979% |
| CohBar, Inc. | - USD | -Infinity% |
| Cognition Therapeutics, Inc. | -252 Thousand USD | 41409.127% |
| NRx Pharmaceuticals, Inc. | -5000.00 USD | 2082080.0% |
| Legend Biotech Corporation | 140.92 Million USD | 26.134% |
| Mural Oncology plc | -2.56 Million USD | 4155.279% |
| Biora Therapeutics, Inc. | -551 Thousand USD | 18992.74% |
| PaxMedica, Inc. Common Stock | - USD | -Infinity% |
| Disc Medicine, Inc. | -100 Thousand USD | 104199.0% |
| Champions Oncology, Inc. | 20.75 Million USD | -401.585% |
| REGENXBIO Inc. | 53.02 Million USD | -96.306% |
| Ensysce Biosciences, Inc. | -5.35 Million USD | 2043.25% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Cellectar Biosciences, Inc. | -192.37 Thousand USD | 54212.541% |
| Edgewise Therapeutics, Inc. | -1.73 Million USD | 6110.335% |
| Vaxart, Inc. | -60.76 Million USD | 271.32% |
| PharmaCyte Biotech, Inc. | - USD | -Infinity% |
| Aldeyra Therapeutics, Inc. | -262.78 Thousand USD | 39714.506% |
| Cellectis S.A. | 18 Thousand USD | -578227.778% |
| Longeveron Inc. | 221 Thousand USD | -47003.62% |
| Repare Therapeutics Inc. | -80.07 Million USD | 230.01% |
| Sarepta Therapeutics, Inc. | 1.09 Billion USD | 90.476% |
| Inozyme Pharma, Inc. | -1.29 Million USD | 8144.745% |
| Revolution Medicines, Inc. | -399.66 Million USD | 126.047% |
| Nymox Pharmaceutical Corporation | - USD | -Infinity% |
| Third Harmonic Bio, Inc. | -35 Thousand USD | 297525.714% |
| ArriVent BioPharma, Inc. Common Stock | - USD | -Infinity% |
| AN2 Therapeutics, Inc. | - USD | -Infinity% |
| Anixa Biosciences, Inc. | 49 Thousand USD | -212346.939% |
| Vertex Pharmaceuticals Incorporated | 8.6 Billion USD | 98.791% |
| Denali Therapeutics Inc. | -93.34 Million USD | 211.521% |
| Revelation Biosciences, Inc. | -25.04 Thousand USD | 415681.46% |
| Veru Inc. | 7.56 Million USD | -1275.892% |
| Corvus Pharmaceuticals, Inc. | -151 Thousand USD | 69039.735% |
| Cingulate Inc. | -582.91 Thousand USD | 17958.258% |
| Passage Bio, Inc. | -3.72 Million USD | 2897.608% |
| Context Therapeutics Inc. | -12.04 Thousand USD | 864422.484% |
| Exicure, Inc. | -1.42 Million USD | 7415.46% |
| Day One Biopharmaceuticals, Inc. | -383 Thousand USD | 27279.896% |
| Oramed Pharmaceuticals Inc. | 2.7 Million USD | -3751.239% |
| Scinai Immunotherapeutics Ltd. | -512.67 Thousand USD | 20405.067% |
| Rhythm Pharmaceuticals, Inc. | 68.12 Million USD | -52.804% |
| Nuvalent, Inc. | - USD | -Infinity% |
| ABVC BioPharma, Inc. | -149.6 Thousand USD | 69681.637% |
| Carisma Therapeutics, Inc. | -59.2 Million USD | 275.825% |
| Unicycive Therapeutics, Inc. | 391 Thousand USD | -26523.785% |
| OmniAb, Inc. | 14.66 Million USD | -609.75% |
| Anew Medical, Inc. | - USD | -Infinity% |
| Fennec Pharmaceuticals Inc. | 19.99 Million USD | -420.677% |
| Lipocine Inc. | -2.85 Million USD | 3751.548% |
| Lexeo Therapeutics, Inc. Common Stock | -1.84 Million USD | 5748.345% |
| Nautilus Biotechnology, Inc. | -5.7 Million USD | 1924.698% |
| SAB Biotherapeutics, Inc. | -1.5 Million USD | 7010.949% |
| G1 Therapeutics, Inc. | 75.31 Million USD | -38.216% |
| Bellerophon Therapeutics, Inc. | -65 Thousand USD | 160252.308% |
| Sage Therapeutics, Inc. | 84.29 Million USD | -23.492% |
| Ocugen, Inc. | -33.53 Million USD | 410.4% |
| Mind Medicine (MindMed) Inc. | -3.16 Million USD | 3392.188% |
| Q32 Bio Inc. | 578 Thousand USD | -17910.208% |
| Brainstorm Cell Therapeutics Inc. | -265 Thousand USD | 39382.642% |
| Alumis Inc. Common Stock | -1.28 Million USD | 8207.399% |
| Equillium, Inc. | 35.95 Million USD | -189.502% |
| Kyverna Therapeutics, Inc. | -1.7 Million USD | 6198.36% |
| Coya Therapeutics, Inc. | 500.67 Thousand USD | -20691.565% |
| CNS Pharmaceuticals, Inc. | -4134.00 USD | 2518218.045% |
| Galera Therapeutics, Inc. | -259 Thousand USD | 40292.664% |
| Evelo Biosciences, Inc. | - USD | -Infinity% |
| Comera Life Sciences Holdings, Inc. | 422.71 Thousand USD | -24526.46% |
| Dominari Holdings Inc. | 2.03 Million USD | -5005.395% |
| Edesa Biotech, Inc. | -183.47 Thousand USD | 56838.667% |
| vTv Therapeutics Inc. | -13.59 Million USD | 865.715% |
| Bio-Techne Corporation | 773.07 Million USD | 86.534% |
| Agios Pharmaceuticals, Inc. | 17.31 Million USD | -501.068% |
| Harmony Biosciences Holdings, Inc. | 460.78 Million USD | 77.408% |
| Prelude Therapeutics Incorporated | -1.16 Million USD | 9004.962% |
| Candel Therapeutics, Inc. | -23.98 Million USD | 534.108% |
| iTeos Therapeutics, Inc. | 11.69 Million USD | -789.963% |
| Nkarta, Inc. | -5.86 Million USD | 1873.709% |
| BioCardia, Inc. | -7.24 Million USD | 1536.046% |
| Iterum Therapeutics plc | -1.75 Million USD | 6048.514% |